Skip to main content
. 2022 Apr 11;12:838039. doi: 10.3389/fonc.2022.838039

Table 1.

Clinical and dosimetric characteristics of the patients analyzed.

Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Clinical Characteristics Age 53 51 63 58 69
Grading G1 G2 G2 G1 G1
TNM Classification pT1b pN1a pT1b pN0 pT2m pN0 pT1b pN1mi pT1b pN0
Staging IIA IA IIA IB IA
Dosimetric Characteristics Beam 1 (MU) 409.7 364.2 253.7 405.3 317.8
Beam 2 (MU) 224.8 240.9 307.6 323.5 290.5
Beam 3 (MU) 251.1 190 231.1 254.7 296.2
Beam 4 (MU) 248.3 176.7 251 194.9 319.6
CTV volume (cc) 955.8 577 589.7 835.8 1225.8
V95% PTV (%) 98.2 98.8 99.8 98 98.4
V105% PTV (%) 0 0 0 0 0
V20Gy Lung IPSI (%) 15.6 12.1 157 13.2 13.3
Mean Dose Heart (Gy) 0.97 0.7 1.82 0.94 1.04
Max Dose Spinal Canal (Gy) 0.54 0.52 0.53 0.7 0.69